Nursing Care Plans Nursing Diagnosis for GI Bleed: 5 Sample Care Plans & Interventions
Choosing the right nursing diagnosis for GI bleed — and building a NANDA-I care plan around it — is one of the most common assignments you’ll meet on a med-surg or critical care rotation. Gastrointestinal bleeding shows up in the ED, in the ICU, and on the NCLEX-RN®, and the nursing priorities shift fast depending on whether the bleed is upper or lower, fast or slow, ongoing or controlled.
This guide walks you through the nursing diagnosis for GI bleed step by step: pathophysiology, what to look for on assessment, the labs and scoring tools to know, the priority interventions with rationales, five sample NANDA-I care plans you can adapt for clinicals, patient-teaching points, and a clean FAQ at the end. Every clinical claim is cited so you can verify it against your textbook or guidelines.
Scope. Educational content for nursing students. Not a substitute for clinical training or guidance from licensed healthcare professionals. Always follow your institution’s protocols and your provider’s orders.
Quick answer. The top NANDA-I nursing diagnoses for a GI bleed are Deficient Fluid Volume, Ineffective Tissue Perfusion, Risk for Decreased Cardiac Output, Acute Pain, and Anxiety. Priority interventions are airway protection, two large-bore IVs, fluid and blood-product resuscitation, PPI infusion (or octreotide for varices), anticoagulant reversal, and endoscopy within 24 hours.
At a glance — pattern → best-fit nursing diagnosis
| What you see at the bedside | Best-fit NANDA-I diagnosis |
|---|---|
| Hypotension, tachycardia, oliguria, declining Hgb | Deficient Fluid Volume |
| Altered mentation, cool/pale extremities, elevated lactate | Ineffective Tissue Perfusion |
| New ectopy on telemetry, electrolyte shifts after resuscitation | Risk for Decreased Cardiac Output |
| Pain score ≥ 4/10, guarding, autonomic changes | Acute Pain |
| Restlessness, voiced fear, rapid respirations | Anxiety |
Common mistakes to avoid. Reaching for NSAIDs for pain control (they worsen mucosal injury). Assuming hypertension reflects bleeding severity (in hypovolemia, BP falls). Waiting for hematemesis before suspecting UGIB (tachycardia is the earliest sign). Using the old “transfuse below Hgb 8” rule for stable patients (AABB 2023 restrictive threshold is < 7 g/dL). Forgetting cirrhotic-patient antibiotic prophylaxis (ceftriaxone) for variceal bleeds.
Table of contents
- What is a GI bleed? Pathophysiology (upper vs. lower)
- Causes & risk factors
- Signs & symptoms
- Nursing assessment
- Labs & diagnostics
- Risk-scoring tools
- Priority nursing interventions for GI bleed
- Medications for GI bleed
- Sample nursing care plans: nursing diagnosis for GI bleed
- Escalation red flags
- Goals & expected outcomes
- Patient teaching & discharge planning
- Practice question
- FAQ
- Related resources
- References
What is a GI bleed? Pathophysiology (upper vs. lower)
A gastrointestinal (GI) bleed is bleeding anywhere along the digestive tract, from the esophagus to the rectum. The single most important anatomic landmark for classifying it is the ligament of Treitz — the suspensory ligament of the duodenum that separates upper from lower bleeding.
- Upper GI bleed (UGIB) — anything proximal to the ligament of Treitz (esophagus, stomach, duodenum).
- Lower GI bleed (LGIB) — anything distal to it (jejunum, ileum, colon, rectum, anus).
The distinction matters because the presentation, diagnostic workup, scoring tools, and management protocols differ. Upper bleeds typically cause hematemesis or melena and prompt an early upper endoscopy. Lower bleeds usually present with hematochezia and trigger colonoscopy or CT angiography depending on stability.
The hemodynamic consequence, however, is the same regardless of where the bleed starts: volume loss reduces preload, cardiac output drops, and tissue perfusion suffers. Catch the trend early and you prevent hemorrhagic shock; miss it and you’re chasing a code.
Causes & risk factors
Upper GI bleed causes
| Cause | Notes |
|---|---|
| Peptic ulcer disease (PUD) | The single most common cause of UGIB; often H. pylori-related or NSAID-induced |
| Esophageal & gastric varices | Seen in cirrhosis / portal hypertension; bleeds are typically brisk |
| Esophagitis & gastritis | Often acid-related or alcohol-related |
| Mallory-Weiss tear | Longitudinal mucosal tear from retching/vomiting |
| Angiodysplasia | Vascular malformations; can affect the stomach or small bowel |
| Gastric or esophageal malignancy | Less common but always on the differential |
Lower GI bleed causes
| Cause | Notes |
|---|---|
| Diverticulosis | Most common single cause of LGIB in adults over 60 |
| Angiodysplasia | Second most common LGIB cause in older adults |
| Inflammatory bowel disease (IBD) | Crohn’s, ulcerative colitis |
| Ischemic colitis | More common in patients with vascular disease |
| Colorectal neoplasia | Always rule out, especially with chronic occult bleeding |
| Hemorrhoids & anal fissures | Usually small-volume hematochezia |
| Infectious colitis | Bacterial (Shigella, EHEC, C. difficile) |
Risk factors that change the clinical picture
- NSAID use — risk increases with age, dose, duration, and concurrent SSRI or anticoagulant therapy
- Anticoagulants and antiplatelets — warfarin, DOACs (apixaban, rivaroxaban, dabigatran), aspirin, P2Y12 inhibitors
- H. pylori infection — test and treat per ACG 2017 guidance
- Cirrhosis / chronic liver disease — raises variceal-bleed risk
- Advanced age (over 65)
- Chronic alcohol use
- Critical illness (stress ulcer prophylaxis is standard in ICUs for a reason)
- Prior GI bleed — strongest single predictor of recurrence
Signs & symptoms
Three vocabulary terms get tested on the NCLEX and asked about in clinicals constantly. Learn them once, use them forever.
| Term | What it looks like | What it usually means |
|---|---|---|
| Hematemesis | Vomiting blood — bright red or coffee-ground | UGIB, active or recent |
| Coffee-ground emesis | Dark, granular, brown vomit | UGIB that’s been in contact with gastric acid (often slowing) |
| Melena | Black, tarry, foul-smelling stool | Usually UGIB; blood in the gut long enough for hemoglobin to oxidize |
| Hematochezia | Bright red blood per rectum | Usually LGIB — but a brisk UGIB can also present this way |
| Occult blood | Positive guaiac (FOBT/FIT) with no visible blood | Slow, chronic GI bleeding |
Upper vs. lower presentation patterns
| Finding | More typical of UGIB | More typical of LGIB |
|---|---|---|
| Hematemesis | ✓ | — |
| Coffee-ground emesis | ✓ | — |
| Melena | ✓✓ | (slow LGIB possible) |
| Hematochezia | (brisk UGIB possible) | ✓✓ |
| Epigastric pain / dyspepsia | ✓ | — |
| Painless rectal bleeding | — | ✓ (diverticular) |
| Elevated BUN:Cr ratio | ✓ | — |
Subjective findings the patient may report
Abdominal pain, nausea, vomiting (note color), lightheadedness or syncope, fatigue, weakness, change in stool color, dyspepsia or heartburn history, recent NSAID use, history of liver disease.
Objective findings to document
Pallor, dry mucous membranes, tachycardia, hypotension, orthostatic blood pressure changes (a drop of 20 mmHg systolic or more from sit to stand is significant), cool clammy skin, restlessness or altered mentation, decreased urine output, and the actual GI findings — hematemesis, melena, or hematochezia on exam or in the chart.
Nursing assessment
Any nursing diagnosis for GI bleed starts with a focused, system-by-system assessment. The pattern below maps directly into the nursing process — assessment first, then diagnosis, planning, implementation, and evaluation.
Health history
- Bleeding history: when did it start? How much blood? Color of vomit or stool?
- Past GI bleeds, peptic ulcer disease, H. pylori treatment history
- Medications: NSAIDs, aspirin, anticoagulants, antiplatelets, SSRIs, corticosteroids
- Alcohol use; tobacco use
- Liver disease, cirrhosis, varices history
- Recent procedures or retching episodes (Mallory-Weiss risk)
Physical assessment by body system
- CNS: mental status (anxious, confused, lethargic), syncope, recent falls
- HEENT: conjunctival pallor, dry mucous membranes
- Respiratory: rate and depth, SpO₂ trend, breath sounds
- Cardiovascular: HR (tachycardia is the earliest sign), BP (hypotension is late — and don’t expect it to rise here; if you see hypertension, suspect pain or a different problem), orthostatic changes, peripheral pulses, capillary refill, telemetry rhythm
- GI: abdominal inspection (distention, prominent veins suggesting portal hypertension), auscultation (hyperactive or absent bowel sounds), palpation (tenderness, masses), characterize any vomit or stool you observe directly
- Genitourinary: urine output q1h — less than 30 mL/hr suggests inadequate perfusion
- Skin: pallor, cool clammy quality, diaphoresis
Labs & diagnostics
| Test | Threshold / interpretation | Source |
|---|---|---|
| Hemoglobin | < 7 g/dL in hemodynamically stable adult → transfuse PRBCs | AABB 2023 |
| Hemoglobin | < 8 g/dL in patient with cardiovascular disease → transfuse PRBCs | AABB 2023 |
| Hematocrit | Trend serially (it may not drop immediately after acute bleed) | — |
| Platelets | < 50,000/μL with active bleeding → transfuse platelets | ACG 2021 |
| INR / PT / aPTT | INR > 1.5 with active bleeding → FFP ± vitamin K | ACG 2021 |
| BUN:creatinine ratio | Elevated in UGIB (digested blood = nitrogen load) | StatPearls |
| Lactate | Elevated suggests tissue hypoperfusion | — |
| Liver function tests | Elevated suggests cirrhosis / variceal etiology | — |
| Type & crossmatch | Always early — required before any transfusion | — |
| 12-lead ECG | Anemia and electrolyte shifts can trigger arrhythmias | — |
Diagnostic procedures
| Procedure | When it’s used | Timing |
|---|---|---|
| Upper endoscopy (EGD) | Suspected or confirmed UGIB | Within 24 hours of admission; within 12 hours if hemodynamically unstable or variceal |
| Colonoscopy | LGIB after adequate bowel prep | Within 24 hours for high-risk LGIB |
| CT angiography | Hemodynamically unstable patient with ongoing LGIB | Before intervention if available |
| Capsule endoscopy | Suspected small-bowel source not found on EGD/colonoscopy | Non-urgent |
| Balloon-assisted enteroscopy | Targeted small-bowel intervention | Non-urgent |
| Nuclear scintigraphy | Slow LGIB (most sensitive) | Non-urgent |
| Fecal occult blood test | Outpatient evaluation of chronic blood loss | Outpatient |
Risk-scoring tools
Knowing the names of these tools — and which one applies when — is high-yield for both clinicals and exam prep.
| Score | Bleed type | Use | Components | Key threshold |
|---|---|---|---|---|
| Glasgow-Blatchford | UGIB | Pre-endoscopy triage | BUN, Hgb, SBP, HR, melena, syncope, hepatic/cardiac disease | Score 0–1 → safe outpatient management |
| Rockall | UGIB | Post-endoscopy mortality prediction | Age, shock, comorbidities, endoscopic diagnosis, evidence of bleeding | Higher score → higher mortality |
| AIMS65 | UGIB | Inpatient mortality | Albumin < 3 g/dL · INR > 1.5 · altered Mental status · SBP ≤ 90 · age ≥ 65 | 1 point per component; more points = higher mortality |
| Oakland | LGIB | Discharge safety | Multi-component clinical + lab | Score ≤ 8 → safe outpatient discharge |
NCLEX-relevant tip. AIMS65 is the easiest to remember because the name is the mnemonic. Albumin, INR, Mental status, SBP, 65 years old.
Priority nursing interventions for GI bleed
The interventions below are the gi bleed nursing interventions you’ll see in every standardized care plan. Each one pairs with a rationale, because “do X because Y” is how you both pass an exam and protect a patient.
| Intervention | Rationale |
|---|---|
| Secure airway and administer supplemental O₂ | Hematemesis and altered mental status both threaten the airway; hypoxia worsens tissue injury |
| Establish two large-bore IVs (16–18 gauge) | Allows rapid crystalloid and blood-product infusion; small-bore lines limit flow rate |
| Keep patient NPO | Reduces vomiting risk, prepares for endoscopy, and protects the airway |
| Aggressive fluid resuscitation with isotonic crystalloid | Restores preload while blood products are being prepared |
| Administer PRBCs, platelets, and FFP per protocol | Replaces lost components; verify ABO/Rh compatibility per facility policy |
| Reverse anticoagulation if applicable | Vitamin K for warfarin; protamine for heparin; andexanet alfa for apixaban/rivaroxaban; idarucizumab for dabigatran |
| Start IV PPI infusion for suspected UGIB | Suppresses gastric acid and stabilizes clot formation on bleeding ulcers |
| Administer octreotide for suspected variceal bleed | Reduces splanchnic blood flow and portal pressure |
| Give ceftriaxone prophylactically in cirrhotic patient | Reduces bacterial infection rate after variceal bleed |
| Give IV erythromycin pre-EGD (per provider order) | Prokinetic — improves endoscopic visualization by clearing gastric blood |
| Continuous hemodynamic monitoring | Trends matter more than single readings; catch decompensation early |
| Monitor urine output q1h | Best bedside indicator of organ perfusion |
| Fall precautions | Orthostatic hypotension and AMS make these patients high fall risk |
| Comfort + anxiety reduction | Explain every procedure; offer family presence; the patient is often terrified |
| Prepare patient for endoscopy | Confirm NPO time, consent, IV access, anesthesia plan |
| Post-procedure airway and bleeding watch | Sedation lingers; bleeding can recur |
Medications for GI bleed
| Drug / class | Indication | Typical dose | Why it works |
|---|---|---|---|
| Pantoprazole / esomeprazole (PPI) | UGIB with high-risk endoscopic stigmata | 80 mg IV bolus → 8 mg/hr infusion × 72 hr (or 80 mg bolus + 40 mg q12h IV) | Suppresses acid; stabilizes clot on ulcers |
| Octreotide | Suspected or confirmed variceal bleed | 50 μg IV bolus, then 50 μg/hr infusion × 3–5 days | Vasoactive — reduces portal pressure |
| Ceftriaxone | Cirrhotic patient with UGIB | 1 g IV daily × 7 days | Prophylaxis against bacterial infection |
| Erythromycin | Pre-EGD when significant gastric blood expected | 250 mg IV once, 30–90 min before EGD | Prokinetic — clears stomach for better visualization |
| Vitamin K | Warfarin reversal | 5–10 mg IV (slow infusion) | Restores synthesis of vitamin-K-dependent factors |
| Protamine sulfate | Heparin reversal | 1 mg per 100 units heparin in last 2–3 hr | Direct binding; neutralizes heparin |
| Andexanet alfa | Apixaban / rivaroxaban reversal | Per package insert (high or low dose) | Decoy that sequesters direct Xa inhibitor |
| Idarucizumab | Dabigatran reversal | 5 g IV (two 2.5 g vials) | Monoclonal antibody fragment binds dabigatran |
| Acetaminophen | Pain control (avoid NSAIDs) | Per facility protocol | Doesn’t worsen platelet function or mucosal injury |
Reminder. Always follow your facility’s policy and provider orders. Doses listed are standard adult ranges from ACG 2021 and AASLD guidance; specific patient circumstances change everything.
Sample nursing care plans: nursing diagnosis for GI bleed
Below are five sample NANDA-I care plans that show how the nursing diagnosis for GI bleed translates into actionable nursing process documentation. Each follows the standard format: diagnosis statement, related factors, defining characteristics, SMART goal, interventions with rationales, and evaluation. Use these as starting points and adapt for your specific patient — they’re built off the most recent NANDA International Nursing Diagnoses 2024–2026 (13th ed.).
Care Plan #1 — Deficient Fluid Volume
The first nursing diagnosis for GI bleed most students choose is Deficient Fluid Volume because it directly names what’s happening: the patient is losing intravascular volume faster than the body can compensate.
Nursing diagnosis. Deficient Fluid Volume related to active GI hemorrhage and excessive vascular volume loss, as evidenced by hypotension (SBP < 90 mmHg or > 20 mmHg drop from baseline), tachycardia, decreased urine output (< 30 mL/hr), dry mucous membranes, hematemesis or melena, and declining hemoglobin.
Goal: Patient will demonstrate restored fluid balance within 24 hours, as evidenced by BP > 90/60 mmHg, HR < 100 bpm, urine output ≥ 30 mL/hr, Hgb ≥ 7 g/dL (≥ 8 with cardiovascular disease), and moist mucous membranes.
| Intervention | Rationale |
|---|---|
| Monitor vital signs q15min until stable | Catches decompensation early; HR rises before BP falls |
| Establish two large-bore IVs; infuse isotonic crystalloid as ordered | Restores intravascular volume before blood products arrive |
| Administer PRBCs per protocol; transfuse at Hgb < 7 (or < 8 with CVD) | Replaces oxygen-carrying capacity; AABB 2023 restrictive strategy |
| Track strict intake and output, including blood loss when measurable | Quantifies the deficit and the resuscitation response |
| Monitor lab trends — CBC, BMP, lactate | Confirms response to therapy and detects ongoing bleeding |
| Place patient in Trendelenburg or modified supine if symptomatically hypotensive | Improves venous return until volume is restored |
| Keep type & crossmatch current | Allows rapid additional transfusion if needed |
Evaluation: Patient meets all measurable criteria above; mucous membranes are moist; mental status is at baseline; lactate is trending toward normal.
Care Plan #2 — Ineffective Tissue Perfusion
Nursing diagnosis. Ineffective Tissue Perfusion (gastrointestinal / peripheral) related to decreased circulating volume and decreased oxygen-carrying capacity, as evidenced by altered mentation, cool pale extremities, capillary refill > 3 seconds, oliguria, elevated lactate, and prolonged orthostatic changes.
Goal: Patient will demonstrate adequate tissue perfusion within 24 hours, as evidenced by alert and oriented mental status, warm dry skin, capillary refill < 3 seconds, urine output ≥ 30 mL/hr, and lactate trending toward normal.
| Intervention | Rationale |
|---|---|
| Administer supplemental oxygen to keep SpO₂ ≥ 94% | Compensates for reduced oxygen-carrying capacity from anemia |
| Assess and document neurologic status q1h | Mental status changes signal worsening perfusion before BP drops further |
| Check capillary refill, peripheral pulses, skin temperature q2h | Direct bedside markers of perfusion |
| Trend lactate every 2–4 hours | Falling lactate = improving perfusion |
| Reposition cautiously; avoid sudden upright movement | Orthostatic drops can precipitate syncope |
| Monitor urine output hourly | Renal perfusion = systemic perfusion |
| Notify provider for any new neurologic or perfusion change | Early escalation prevents arrest |
Evaluation: Patient remains alert and oriented; capillary refill < 3 seconds; urine output ≥ 30 mL/hr; lactate normal or trending normal; extremities warm.
Care Plan #3 — Risk for Decreased Cardiac Output
Nursing diagnosis. Risk for Decreased Cardiac Output related to hypovolemia and potential electrolyte disturbances from blood loss and large-volume resuscitation. Risk factors: active hemorrhage, anemia, possible arrhythmia from electrolyte shifts, age > 65, history of cardiovascular disease.
A “risk-for” diagnosis has risk factors — not defining characteristics — because the problem hasn’t happened yet. The goal is prevention.
Goal: Patient will maintain adequate cardiac output throughout hospitalization, as evidenced by a regular cardiac rhythm on telemetry, BP within the patient-specific target range, no chest pain, and balanced fluid intake and output.
| Intervention | Rationale |
|---|---|
| Place patient on continuous telemetry | Detects arrhythmias triggered by anemia or electrolyte shifts |
| Obtain 12-lead ECG on admission and PRN | Establishes baseline and captures changes |
| Monitor electrolytes — K⁺, Mg²⁺, Ca²⁺, ionized Ca²⁺ | Massive transfusion can drop calcium; lactated Ringer’s contains K⁺ |
| Watch for transfusion reactions during PRBC administration | Reactions can range from fever to acute hemolysis |
| Maintain accurate I&O | Both under-resuscitation and fluid overload damage the heart |
| Assess for chest pain, dyspnea, palpitations q1h while unstable | Demand ischemia is common in elderly patients with low Hgb |
| Coordinate with provider on cardiac troponin trending if symptomatic | Anemia-induced demand ischemia changes management |
Evaluation: Patient remains in sinus rhythm without ectopy; electrolytes within normal limits; no chest pain reported; vital signs at baseline.
Care Plan #4 — Acute Pain
Nursing diagnosis. Acute Pain related to gastric or variceal mucosal injury and procedure-related discomfort, as evidenced by patient-reported pain score (e.g., 6/10), guarding, restlessness, elevated HR and BP, and facial grimacing.
Goal: Patient will report pain ≤ 3/10 within 60 minutes of analgesic administration, with no signs of nonverbal distress, while avoiding NSAIDs that would worsen bleeding.
| Intervention | Rationale |
|---|---|
| Assess pain using a 0–10 scale q1h while acute | Quantifies pain and tracks response |
| Administer acetaminophen as ordered; avoid NSAIDs and aspirin | NSAIDs worsen mucosal injury and platelet function |
| Use opioids cautiously per provider order | Opioids can mask symptoms and lower BP — titrate carefully |
| Reposition for comfort; provide blankets, oral care, calm environment | Non-pharmacologic measures reduce sympathetic stimulation |
| Educate patient on rationale for avoiding NSAIDs | Prevents recurrence after discharge |
| Reassess pain 30–60 minutes after each intervention | Validates effectiveness and identifies escalation needs |
Evaluation: Patient reports pain ≤ 3/10; no guarding or grimacing; HR and BP within accepted range; verbalizes understanding of NSAID-avoidance plan.
Care Plan #5 — Anxiety
Nursing diagnosis. Anxiety related to threat to physiologic integrity, hospitalization, and fear of recurrent bleeding or invasive procedures, as evidenced by verbalized fear, increased HR and respiratory rate, restlessness, difficulty concentrating, and scanning behavior.
Goal: Patient will verbalize reduced anxiety within 8 hours, as evidenced by a calm affect, slower respiratory rate, ability to articulate the plan of care, and improved coping verbalization.
| Intervention | Rationale |
|---|---|
| Use a calm, unhurried approach at the bedside | Anxiety is contagious in both directions — your composure helps |
| Explain every procedure before performing it | Predictability reduces fear |
| Encourage the patient to ask questions | Voicing concerns reduces helplessness |
| Allow family presence when policy permits | Social support is one of the most effective anti-anxiety tools we have |
| Teach simple breathing techniques (4-second inhale, 6-second exhale) | Activates parasympathetic tone |
| Coordinate with provider for short-term anxiolytic if needed | Pharmacologic option when behavioral measures aren’t enough |
| Document the patient’s stated worries | Often catches misconceptions that targeted teaching can fix |
Evaluation: Patient appears calm; verbalizes the plan of care in own words; respiratory rate within normal limits; reports decreased anxiety.
Escalation red flags
Call the provider and activate rapid response for any of these:
| Red flag | What it means | Action |
|---|---|---|
| SBP < 90 mmHg or > 30 mmHg drop from baseline | Hemorrhagic shock developing | Page provider; bolus fluid; ready blood products |
| HR > 120 with falling BP | Late compensatory tachycardia failing | Page provider; ready blood products |
| New altered mental status | Cerebral hypoperfusion | Page provider STAT; protect airway |
| Urine output < 30 mL/hr (< 0.5 mL/kg/hr) | Renal hypoperfusion | Notify provider; reassess fluid status |
| Lactate rising above baseline | Worsening tissue hypoperfusion | Notify provider; escalate resuscitation |
| Massive hematemesis or bright red rectal bleeding | Active uncontrolled hemorrhage | Call rapid response; ready massive transfusion protocol |
| New chest pain or ST changes on telemetry | Anemia-induced demand ischemia | 12-lead ECG; notify provider; trend troponin |
| Failed reversal of anticoagulant with continued bleeding | Inadequate reversal | Provider, hematology consult, additional reversal agent |
Goals & expected outcomes
Goals for the nursing diagnosis for GI bleed should be SMART: Specific, Measurable, Achievable, Relevant, and Time-bound. The table below ties each NANDA-I diagnosis above to its measurable outcome.
| NANDA-I diagnosis | SMART outcome |
|---|---|
| Deficient Fluid Volume | Hgb ≥ 7 g/dL (≥ 8 with CVD) within 24 hr; HR < 100; SBP > 90; urine output ≥ 30 mL/hr |
| Ineffective Tissue Perfusion | Alert and oriented mental status; capillary refill < 3 sec; lactate normal within 24 hr |
| Risk for Decreased Cardiac Output | Sinus rhythm without ectopy; electrolytes within normal limits; no chest pain throughout hospitalization |
| Acute Pain | Pain ≤ 3/10 within 60 min of intervention; no nonverbal distress |
| Anxiety | Calm affect within 8 hr; able to articulate plan of care in own words |
Patient teaching & discharge planning
Patient teaching is where you protect the next admission. Cover these points before discharge — verbally and in writing.
| Teaching point | Why it matters |
|---|---|
| Avoid chronic NSAID use; acetaminophen is the safer first-line analgesic. If NSAIDs are necessary, use lowest effective dose with a PPI cover. | NSAIDs are the leading reversible cause of recurrent UGIB |
| Treat H. pylori if positive (urea breath test or stool antigen → triple/quadruple therapy). | Eradication dramatically reduces ulcer recurrence |
| Address alcohol use, especially if cirrhotic; expect beta-blocker prophylaxis (propranolol or nadolol). | Reduces portal pressure and variceal-rebleed risk |
| Review all anticoagulants and antiplatelets with the prescriber before any restart. | Premature restart causes rebleed; missed restart causes thrombotic events |
| Take the prescribed PPI as directed for the full course. | Stopping early is a common rebleed trigger |
| Resume normal diet unless the provider specifies otherwise. | “Bland diet” alone doesn’t prevent rebleed and may cause undernutrition |
| Return to the ED for new hematemesis, melena, hematochezia, lightheadedness, syncope, chest pain, or palpitations. | Early presentation saves lives |
Practice question
A 68-year-old patient with a history of cirrhosis and esophageal varices presents with hematemesis. Vital signs: BP 88/52, HR 124, RR 24, SpO₂ 94%. Which of the following nursing interventions should the nurse implement first?
- A. Administer pantoprazole 80 mg IV bolus
- B. Establish two large-bore IVs and begin isotonic crystalloid
- C. Insert a nasogastric tube for lavage
- D. Prepare the patient for upper endoscopy
Answer: B. The patient is hemodynamically unstable (hypotension, tachycardia, tachypnea). The first priority after airway and breathing is circulation — establish IV access and begin volume resuscitation. PPI (A) and EGD prep (D) are important but follow stabilization. NG lavage (C) is not first-line — give erythromycin pre-EGD instead, per ACG 2021. Octreotide and ceftriaxone are also indicated given the variceal history, but IV access has to come first.
FAQ
What is the nursing care plan for a GI bleed?
A nursing care plan for GI bleed centers on five NANDA-I diagnoses — Deficient Fluid Volume, Ineffective Tissue Perfusion, Risk for Decreased Cardiac Output, Acute Pain, and Anxiety. Each pairs a measurable SMART goal with nursing interventions like establishing large-bore IV access, continuous hemodynamic monitoring, blood-product administration, PPI infusion, anticoagulant reversal, and patient teaching. The full sample plans are in the sample care plans section above.
What are the top nursing interventions for a GI bleed?
The priority gi bleed nursing interventions are: secure ABCs (airway, breathing, circulation), place two large-bore IVs, monitor hemodynamics continuously, administer fluids and blood products per protocol, give a PPI for suspected UGIB (or octreotide if variceal bleeding is suspected), reverse anticoagulants if present, keep the patient NPO, and prepare for upper or lower endoscopy within 24 hours of presentation.
What NANDA-I nursing diagnoses apply to GI bleeding?
The most common nursing diagnosis for GI bleed in the acute phase is Deficient Fluid Volume related to active hemorrhage. Ineffective Tissue Perfusion, Risk for Decreased Cardiac Output, Acute Pain, and Anxiety round out the top five NANDA-I diagnoses used in standardized care plans for GI bleeding patients.
What is the difference between upper and lower GI bleeding?
The ligament of Treitz separates them. Upper GI bleeds (proximal) most commonly present as hematemesis or melena and are most often caused by peptic ulcer disease or varices. Lower GI bleeds (distal) typically present as hematochezia and are most often caused by diverticulosis or angiodysplasia.
What hemoglobin level requires transfusion in GI bleed?
For hemodynamically stable patients with GI bleeding, the AABB 2023 clinical practice guideline recommends transfusing red blood cells when hemoglobin drops below 7 g/dL. For patients with preexisting cardiovascular disease, the threshold is below 8 g/dL.
What’s the difference between hematemesis, melena, and hematochezia?
Hematemesis is vomiting blood — bright red indicates active upper GI bleeding, and coffee-ground emesis indicates older, acid-modified blood. Melena is black, tarry, foul-smelling stool — usually upper GI in origin because blood needs time in the gut to become oxidized. Hematochezia is bright red blood per rectum — usually lower GI, but a brisk upper GI bleed can also present this way.
What causes GI bleeding?
Peptic ulcer disease is the single most common cause of upper GI bleeding; diverticulosis is the most common cause of lower GI bleeding in older adults. Other causes include varices, esophagitis, gastritis, IBD, angiodysplasia, colorectal cancer, hemorrhoids, and ischemic colitis. NSAID use, anticoagulants, H. pylori infection, and cirrhosis substantially raise the risk.
How can patients prevent recurrent GI bleeding?
Avoid chronic NSAID use; treat H. pylori infection if present; manage alcohol use (essential in variceal disease); take any prescribed PPI for the full course; control cirrhosis with beta-blocker prophylaxis if indicated; and review every anticoagulant or antiplatelet medication with the prescriber. Return to the ED immediately for any new hematemesis, melena, hematochezia, lightheadedness, or syncope.
Related resources
Related care plans
- Ineffective Tissue Perfusion Nursing Care Plan — the broader perfusion framework behind GI-bleed Care Plan #2
- Decreased Cardiac Output Nursing Care Plan — complements GI-bleed Care Plan #3
- Acute Pain Nursing Care Plan — deeper coverage for GI-bleed Care Plan #4
- Anxiety Nursing Care Plan — deeper coverage for GI-bleed Care Plan #5
- Anemia Nursing Care Plan — the common downstream condition after blood loss
References
- Antunes C, Tian C, Copelin EL, Saleh A, et al. Upper Gastrointestinal Bleeding. StatPearls — NCBI Bookshelf NBK537291. Updated 2024. View
- Strate LL, Gralnek IM. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding. Am J Gastroenterol. 2016;111(4):459–474. View
- Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390(10094):613–624.
- Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017;112(2):212–239.
- Carson JL, Stanworth SJ, Guyatt G, Valentine S, et al. Red Blood Cell Transfusion: 2023 AABB International Collaboration Clinical Practice Guidelines. JAMA. 2023;330(19):1892–1902.
- Laine L, Barkun AN, Saltzman JR, Martel M, Leontiadis GI. ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding. Am J Gastroenterol. 2021;116(5):899–917.
- Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet. 2000;356(9238):1318–1321.
- Rockall TA, Logan RFA, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38(3):316–321.
- Saltzman JR, Tabak YP, Hyett BH, et al. A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 2011;74(6):1215–1224.
- Oakland K, Jairath V, Uberoi R, et al. Derivation and validation of a risk score for safe discharge of adults with acute lower gastrointestinal bleeding. Lancet Gastroenterol Hepatol. 2017;2(9):635–643.
- Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis — 2016 AASLD practice guidance. Hepatology. 2017;65(1):310–335.
- Herdman TH, Kamitsuru S, Lopes CT, eds. NANDA International Nursing Diagnoses: Definitions and Classification 2024–2026 (13th ed.). New York: Thieme.
- Lippincott Manual of Nursing Practice, 11th ed. Philadelphia: Wolters Kluwer; 2023.
- Silvestri LA, Silvestri AE. Saunders Comprehensive Review for the NCLEX-RN Examination, 9th ed. St. Louis: Elsevier; 2023.
Source notes. Care-plan diagnoses, related factors, and defining characteristics reflect NANDA International 2024–2026 (13th ed.). Clinical thresholds reflect the ACG 2016/2017/2021, AASLD 2017, and AABB 2023 guidelines current as of June 2026. Always check the latest edition of these resources and your facility’s protocols before applying clinical guidance.
